Hospira Dobutamine 12.5 mg/mL Sterile Concentrate 250 mg/20 mL vial

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

dobutamine hydrochloride, Quantity: 14.01 mg/mL (Equivalent: dobutamine, Qty 12.5 mg/mL)

Pieejams no:

Hospira Australia Pty Ltd

SNN (starptautisko nepatentēto nosaukumu):

dobutamine hydrochloride

Zāļu forma:

Injection, concentrated

Kompozīcija:

Excipient Ingredients: sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide

Ievadīšanas:

Intravenous Infusion

Vienības iepakojumā:

1 x 20 mL

Klase:

Medicine Listed (Export Only)

Receptes veids:

Not scheduled. Not considered by committee

Ārstēšanas norādes:

Dobutamine is indicated for adults who require inotropic support in the treatment of low output cardiac failure associated with organic heart disease, myocardial infarction, open heart surgery, cardiomyophathies, septic shock and cardiogenic shock. Dobutamine can increase or maintain cardiac output during positive end expiratory pressure ventilation.

Produktu pārskats:

Visual Identification: A clear colourless or slightly yellow solution free from visible particulate matter; Container Type: Vial; Container Life Time: 2 Years; Container Temperature: Store below 25 degrees Celsius

Autorizācija statuss:

Listed (Export Only)

Autorizācija datums:

2007-03-27